RE:RE:RE:MarketsMoney, you are assuming they will have the listing completed before any deal. Look at the state of the TSX and Venture exchanges. The crash is only starting so I think that short of a deal with some MAJOR pharma, the outlook is grim. Then again, you never really know what will happen but my bet is it will be lacklustre. The timing is awful and would have been much better when the market was in euphoria. This is also assuming that they will even get any deal done in the near future.
I'm still convinced by the trading and tight range that the price is being kept at 1.40 for some kind of $ transaction. The only thing that makes sense to me is the pharma will give SVA money in exchange for shares on top of whatever the deal will entail. At which price, I have no idea but I'm feeling very certain that there will be dilution.
The second problem is there are a lot of investors who are tired of holding and have made 10x and ready to get out of their large positions to sit on cash until the market begins to show some signs of recovery. Unless there is new demand, it will put a lot of downward pressure on the price should they not like the deal and want to stay vested. Keep in mind there are millions of warrants that will be in the money at 1.70. I could even expect those folks to short the stock on any price increase above 2.00.
My guess is we don't see anything sustainable North of $2.00 in the best case scenario. Could be wrong (hopefully I am) but that is my analysis of the current situation.
MoneyMouth wrote: Do you think an uplisting to the TSX could create enough buying pressure combat the selling pressure on news?